Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 52,222 | 45,658 | 26,502 | 20,619 | 22,576 |
| Cost of Goods | 28,817 | 19,458 | 11,237 | 9,197 | 9,521 |
| Gross Profit | 23,405 | 26,200 | 15,265 | 11,421 | 13,055 |
| Operating Expenses | 48,339 | 47,120 | 50,615 | 32,469 | 25,027 |
| Operating Income | -24,117 | -20,462 | -35,113 | -20,850 | -11,452 |
| Other Income | -122 | -22 | -13 | 44 | 24 |
| Pre-tax Income | -24,239 | -20,484 | -35,127 | -20,807 | -11,428 |
| Income Tax | 100 | 175 | 25 | -300 | N/A |
| Net Income Continuous | -24,339 | -20,659 | -35,152 | -20,507 | -11,428 |
| Net Income | $-24,339 | $-20,659 | $-35,152 | $-20,507 | $-11,428 |
| EPS Basic Total Ops | -0.16 | -0.14 | -0.27 | -0.16 | -0.10 |
| EPS Basic Continuous Ops | -0.16 | -0.14 | -0.27 | -0.16 | -0.10 |
| EPS Diluted Total Ops | -0.16 | -0.14 | -0.27 | -0.16 | -0.10 |
| EPS Diluted Continuous Ops | -0.16 | -0.14 | -0.27 | -0.16 | -0.10 |
| EPS Diluted Before Non-Recurring Items | -0.16 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-22,256 | $-18,882 | $-33,869 | $-20,147 | $-11,154 |